Cargando…

von Willebrand Factor: A Central Regulator of Arteriovenous Fistula Maturation Through Smooth Muscle Cell Proliferation and Outward Remodeling

BACKGROUND: Arteriovenous fistula (AVF) maturation failure is a main limitation of vascular access. Maturation is determined by the intricate balance between outward remodeling and intimal hyperplasia, whereby endothelial cell dysfunction, platelet aggregation, and vascular smooth muscle cell (VSMC)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laboyrie, Suzanne L., de Vries, Margreet R., de Jong, Alwin, de Boer, Hetty C., Lalai, Reshma A., Martinez, Laisel, Vazquez‐Padron, Roberto I., Rotmans, Joris I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496319/ https://www.ncbi.nlm.nih.gov/pubmed/35929448 http://dx.doi.org/10.1161/JAHA.121.024581

Ejemplares similares

Building a Scaffold for Arteriovenous Fistula Maturation: Unravelling the Role of the Extracellular Matrix
por: Laboyrie, Suzanne L., et al.
Publicado: (2023)

Deficiency of TLR4 homologue RP105 aggravates outward remodeling in a murine model of arteriovenous fistula failure
por: Bezhaeva, Taisiya, et al.
Publicado: (2017)

Liposomal prednisolone inhibits vascular inflammation and enhances venous outward remodeling in a murine arteriovenous fistula model
por: Wong, ChunYu, et al.
Publicado: (2016)

Considering the Closure of Arteriovenous Fistulas in Kidney Transplant Recipients
por: Xiao, Zhuotao, et al.
Publicado: (2023)

Echocardiographic changes after arteriovenous fistula creation in hemodialysis patients
por: Manzur-Pineda, Karen, et al.
Publicado: (2022)

Von Willebrand Disease: From In Vivo to In Vitro Disease Models
por: de Boer, Suzan, et al.
Publicado: (2019)

Hemophilia and von Willebrand disease: Factor VIII and von Willebrand factor
por: Sharma, Prashant
Publicado: (2019)

Porcine and Canine von Willebrand Factor and von Willebrand Disease: Hemostasis, Thrombosis, and Atherosclerosis Studies
por: Nichols, Timothy C., et al.
Publicado: (2010)

Differences in von Willebrand factor function in type 2A von Willebrand disease and left ventricular assist device‐induced acquired von Willebrand syndrome
por: Deconinck, Shannen, et al.
Publicado: (2018)

Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease
por: Casonato, Alessandra, et al.
Publicado: (2016)

Interfering in the ALK1 Pathway Results in Macrophage-Driven Outward Remodeling of Murine Vein Grafts
por: de Jong, Alwin, et al.
Publicado: (2022)

Periadventitial β-aminopropionitrile-loaded nanofibers reduce fibrosis and improve arteriovenous fistula remodeling in rats
por: Applewhite, Brandon, et al.
Publicado: (2023)

Long-Term Controlled Growth Factor Release Using Layer-by-Layer Assembly for the Development of In Vivo Tissue-Engineered Blood Vessels
por: Damanik, Febriyani F. R., et al.
Publicado: (2022)

Von Willebrand Factor Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease
por: Boender, Johan, et al.
Publicado: (2021)

Changes of von Willebrand Factor during Pregnancy in Women with and without von Willebrand Disease
por: Castaman, Giancarlo
Publicado: (2013)

Genetic Variation in the von Willebrand Factor Gene in Swedish von Willebrand Disease Patients
por: Manderstedt, Eric, et al.
Publicado: (2018)

Variability of von Willebrand factor‐related parameters in endothelial colony forming cells
por: de Jong, Annika, et al.
Publicado: (2019)

Von Willebrand Disease: An Overview
por: Bharati, K. Pavani, et al.
Publicado: (2011)

On the Versatility of von Willebrand Factor
por: Rauch, Antoine, et al.
Publicado: (2013)

Of von Willebrand factor and platelets
por: Bryckaert, Marijke, et al.
Publicado: (2014)

Classification of von Willebrand disease in the context of modern contemporary von Willebrand factor testing methodologies
por: Favaloro, Emmanuel J.
Publicado: (2020)

Improving diagnosis of von Willebrand disease: Reference ranges for von Willebrand factor multimer distribution
por: Vangenechten, Inge, et al.
Publicado: (2020)

Natural Vascular Scaffolding Treatment Promotes Outward Remodeling During Arteriovenous Fistula Development in Rats
por: Shiu, Yan-Ting, et al.
Publicado: (2021)

Current therapy in children and adolescents with von Willebrand disease
por: Buga-Corbu, I, et al.
Publicado: (2014)

von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis
por: Kalot, Mohamad A., et al.
Publicado: (2021)

Effect of Genetic Variation in STXBP5 and STX2 on von Willebrand Factor and Bleeding Phenotype in Type 1 von Willebrand Disease Patients
por: van Loon, Janine E., et al.
Publicado: (2012)

Comorbidities associated with higher von Willebrand factor (VWF) levels may explain the age‐related increase of VWF in von Willebrand disease
por: Atiq, Ferdows, et al.
Publicado: (2018)

Interaction of von Willebrand factor with blood cells in flow models: a systematic review
por: Arisz, Ryanne A., et al.
Publicado: (2022)

Treatment of patients with von Willebrand disease
por: Tuohy, Emma, et al.
Publicado: (2011)

The Molecular Genetics of von Willebrand Disease
por: Berber, Ergül
Publicado: (2012)

Von Willebrand Factor, Angiodysplasia and Angiogenesis
por: Randi, Anna M., et al.
Publicado: (2013)

Regulation of plasma von Willebrand factor
por: Desch, Karl C
Publicado: (2018)

Von Willebrand's Disease: Pathogenesis and Management
por: Dormandy, Katharine M.
Publicado: (1969)

Report on von Willebrand Disease in Malaysia
por: Periayah, Mercy Halleluyah, et al.
Publicado: (2016)

Von Willebrand Factor Inhibits Mature Smooth Muscle Gene Expression through Impairment of Notch Signaling
por: Meng, He, et al.
Publicado: (2013)

Von Willebrand disease type Vicenza: In search of a classification for the archetype of reduced von Willebrand factor survival
por: Casonato, Alessandra, et al.
Publicado: (2021)

Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results
por: Leebeek, Frank W. G., et al.
Publicado: (2022)

ADAMTS‐13 and bleeding phenotype in von Willebrand disease
por: Boender, Johan, et al.
Publicado: (2020)

Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A
por: Castaman, Giancarlo, et al.
Publicado: (2016)

In Vitro Assessment of von Willebrand Factor in Cryoprecipitate, Antihemophilic Factor/VWF Complex (Human), and Recombinant von Willebrand Factor
por: Colling, Meaghan E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cbpmm0v16cuqs56uhmumbvq53k